Glaxo to Share Vaccine Technology With Brazil as Part of Sales Pact. By . Jeanne Whalen. Share. Resize. In an effort to crack the lucrative Brazilian market, GlaxoSmithKline PLC has agreed to give ...

More emerging-markets action for GlaxoSmithKline (GSK). The drugmaker has inked a $2.2 billion deal to supply its Synflorix vaccine to Brazil, one of the hottest drug markets in the developing world.

GlaxoSmithKline has sealed an innovative €1.5bn (£1.38bn) contract with Brazil guaranteeing sales of its pneumococcal vaccine, designed to prevent pneumonia and meningitis, over the entire life ...

Drug giants GlaxoSmithKline and Sanofi Pasteur said Friday they had won a commitment from the US federal government to pay up to $2.1 billion to help the two companies move forward ... Brazil, and ...

LONDON, Sept 28 (Reuters) - GlaxoSmithKline Plc sealed a 1.5 billion euro ($2.2 billion) deal with Brazil guaranteeing sales of its pneumococcal vaccine for 10 years, the company said on Monday ...

GlaxoSmithKline and Brazil by Friday are expected to sign an agreement that would reduce the cost of GSK's antiretroviral Abacavir by 27% in the country, an unnamed health ministry official ...

GlaxoSmithKline agreed Thursday to release all data on the safety and effectiveness of its drugs to settle a lawsuit by New York's attorney general, who accused the pharmaceutical maker of ...

On Monday morning, GlaxoSmithKline and Verily Life Sciences, which is owned by Google’s parent, Alphabet, formed a new company that will fight diseases by targeting electrical signals in the ...

If Glaxo’s dolutegravir makes it possible to treat HIV with a two-drug regimen, instead of a three-drug combination, it would be a game-changer, said Andrew Witty, the drugmaker’s CEO.

GlaxoSmithKline PLC <GSK.L> has sealed a 1.5 billion euro (1.38 billion pound) deal with Brazil, guaranteeing sales of its pneumococcal vaccine over the entire life of the product, the Financial ...